Literature DB >> 2795454

Differential effects of the degree of renal damage on p-aminohippuric acid and inulin clearances in rats.

C A Gloff1, L Z Benet.   

Abstract

Kidney disease is generally thought to affect all segments of a nephron equally. Bricker and co-workers first proposed this as the Intact Nephron hypothesis in 1971, and evidence to date has usually supported this hypothesis. However, most supporting studies have involved severe renal failure, which may not be suitable to differentiate effects on functional sites or to test the hypothesis. The work included here examines the effects of limited renal failure on two separate functions of the nephron: glomerular filtration, as measured by inulin clearance and proximal tubular organic anion secretory function, as measured by p-aminohippuric acid (PAH) clearance. Renal failure was induced in rats by intravenous administration of uranyl nitrate, a nephrotoxin. Doses used were 0.3, 1.0, and 3.0 mg/kg rat body weight. Five days later, rats were given an intravenous infusion of PAH and inulin. Renal clearance of each compound was calculated. Results obtained in these experiments show that, at the lowest uranyl nitrate dose, PAH clearance was significantly decreased but inulin clearance was not. The ratio of CLPAH/CLIN was decreased from 2.55 in control rats to 1.21 in rats given the low dose of nephrotoxin. At higher uranyl nitrate doses, both clearance rates were significantly decreased and the ratio of CLPAH/CLIN remained close to 1.0. These results indicate that the active transport functions of the nephron can be differentiated from passive transport functions. Caution should be exercised in extrapolating renal disease changes in active renal secretion to changes in passive renal elimination and the reverse.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2795454     DOI: 10.1007/bf01059026

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  23 in total

1.  Pathophysiology of a nephrotoxic model of acute renal failure.

Authors:  J H Stein; J Gottschall; R W Osgood; T F Ferris
Journal:  Kidney Int       Date:  1975-07       Impact factor: 10.612

2.  The initiation phase of experimental acute renal failure: an evaluation of uranyl nitrate-induced acute renal failure in the rat.

Authors:  W Flamenbaum; R J Hamburger; M L Huddleston; J Kaufman; J S McNeil; J H Schwartz; R Nagle
Journal:  Kidney Int Suppl       Date:  1976-10       Impact factor: 10.545

Review 3.  The pathophysiology of renal insufficiency. On the functional transformations in the residual nephrons with advancing disease.

Authors:  N S Bricker; S Klahr; H Lubowitz; E Slatopolsky
Journal:  Pediatr Clin North Am       Date:  1971-05       Impact factor: 3.278

4.  Chronic vascular constrictions and measurements of renal function in conscious rats.

Authors:  M Gellai; H Valtin
Journal:  Kidney Int       Date:  1979-04       Impact factor: 10.612

5.  The mechanism of acute renal failure after uranyl nitrate.

Authors:  R C Blantz
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

7.  Influence of uranyl nitrate upon tubular reabsorption and glomerular filtration in blood perfused isolated dog kidneys.

Authors:  A Nizet
Journal:  Pflugers Arch       Date:  1981-10       Impact factor: 3.657

8.  Renal hemodynamics in oliguric and nonoliguric acute renal failure of rabbits.

Authors:  M Sudo; N Honda; A Hishida; M Nagase
Journal:  Nephron       Date:  1980       Impact factor: 2.847

9.  Effect of experimental azotemia on renal clearance of furosemide in the dog.

Authors:  H J Rose; A W Pruitt; J L McNay
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

10.  The long-term effects of uranyl nitrate on the structure and function of the rat kidney.

Authors:  D P Haley; R E Bulger; D C Dobyan
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1982
View more
  10 in total

Review 1.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

2.  Physiological modelling of renal drug clearance.

Authors:  I Janků
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 3.  Nonlinear kinetics and the 1-exp function in nephropharmacology.

Authors:  F Keller; K Erdmann; M Giehl
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  A general empirical model for renal drug handling in pharmacokinetic analyses.

Authors:  Daniel F B Wright; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2017-05-10       Impact factor: 4.335

5.  Quantitative analysis of drug handling by the kidney using a physiological model of renal drug clearance.

Authors:  I Janků; K Zvára
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin.

Authors:  F Keller; K Erdmann; M Giehl; P Buettner
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

7.  The relation between type of renal disease and renal drug clearance in children.

Authors:  C M Paap; M C Nahata
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  An experimental model for pharmacokinetic analysis in renal failure.

Authors:  N E Duffee; R F Bevill; G D Koritz; D J Schaeffer
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

Review 9.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

10.  Prediction of the renal clearance of cimetidine using endogenous N-1-methylnicotinamide.

Authors:  A Maiza; P T Daley-Yates
Journal:  J Pharmacokinet Biopharm       Date:  1991-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.